Healthcare utilisation and costs for temporomandibular disorders: a descriptive, cross-sectional study.

Hyejin SeoBoyoung JungJiyoon YeoKoh-Woon KimJae-Heung ChoYoon-Jae Lee In Hyuk Ha

Published in: BMJ open (2020)

While people with TMD most commonly received temporomandibular stimulation therapy, the costs and duration of treatment varied significantly for these patients.

Keyphrases

healthcare
end stage renal disease
ejection fraction
chronic kidney disease
peritoneal dialysis
stem cells
cross sectional
patient reported outcomes
mesenchymal stem cells
patient reported